Nanomi is leader in the field of microsphere and nanoparticle development of long-acting release injectables. The company is located in the green surroundings of Oldenzaal and is a subsidiary of Lupin ltd. The Nanomi team is young and internationally oriented. The working atmosphere is informal and dynamic, with personal development and humor as important pillars. Nanomi has developed a cutting-edge technology - the Microsieve technology - for the development of long-acting release medicines, a technology that offers unprecedented drug development potential for the future. The Microsieve technology is unique in that it guarantees production of medicines with uniform particle size, uniform particle shape and uniform biological properties. These properties safeguard precise dosing of the medicines over long periods of time. The technology is proven robust, scalable and cost effective, and is applicable to a myriad of pharmaceutical compounds. It represents an unprecedented potential in development of long-acting release medicines. With the Microsieve technology, Nanomi offers reliable solutions for complex challenges in the pharmaceutical industry.